XML 60 R35.htm IDEA: XBRL DOCUMENT v3.25.1

STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of assumptions for options granted

Schedule of assumptions for options granted
		Year ended December 31,
		2024				2023
Expected volatility			89.04% - 92.70%				90.25% - 94.51%
Expected term			5 - 7 Years				5 - 7 Years
Risk-free interest rate			3.63% - 4.48%				3.55% - 4.47%
Weighted-average FV			$4.02				$5.93

Schedule of option activity

Schedule of option activity
						Weighted				Weighted		Aggregate
						Average				Average		Intrinsic
		Number of				Exercise				Remaining		Value
		Options				Price				Contractual Life		(in thousands)
Outstanding at December 31, 2022			336,758			$	12.54
Granted			169,800				7.54
Forfeited			(24,700	)			19.70
Outstanding at December 31, 2023			481,858			$	10.41			7.25 Years		$	350
Exercisable at December 31, 2023			151,310			$	5.55			7.18 Years		$	233
Granted			358,700				5.13
Forfeited			177,554				9.92
Outstanding at December 31, 2024			663,004			$	6.69			7.75 Years		$	–
Exercisable at December 31, 2024			384,755			$	8.63			6.65 Years		$	–

STOCKHOLDERS' EQUITY (Details - Schedule of RSU activity)

Schedule of RSU activity
		Shares			Weighted Average Grant Date Fair Value
Unvested at beginning of 2024		71			$	13.05
Granted		–				–
Vested		(36	)		$	7.25
Forfeited		–				–
Unvested at end of 2024		36			$	13.05

Schedule of RSU activity

Schedule of RSU activity		Shares			Weighted Average Grant Date Fair Value
Unvested at beginning of 2024		143			$	13.05
Granted		45			$	13.05
Vested		(187	)		$	7.25
Forfeited		–				–
Unvested at end of 2024		–				–

Schedule of restricted stock awards

Schedule of restricted stock awards
						Weighted-
		Nonvested				Average Grant-
		Shares				Date Fair Value
Nonvested at December 31, 2022		$	17,865			$	14.11
Granted			19,795				10.98
Vested			(31,022	)			12.29
Forfeited			(5,400	)			11.68
Nonvested at December 31, 2023		$	1,238			$	20.17
Granted			80,645				6.20
Vested			(71,803	)			6.44
Forfeited			(10,080	)			6.20
Nonvested at December 31, 2024		$	–			$	–

Schedule of warrant outstanding

Schedule of warrant outstanding
		Number of Warrants				Weighted Average Exercise Price
Outstanding at December 31, 2022			440,204			$	6.30
Granted			200,000				17.00
Exercised			(29,459	)			6.30
Outstanding at December 31, 2023			610,745			$	9.80
Granted			–				–
Expired			(282,334	)			6.40
Exercised			(128,411	)			6.30
Outstanding at December 31, 2024			200,000				17.00
Exercisable at December 31, 2024			200,000			$	17.00

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested performance-based units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration